News from the healthcare data industry
Cedars-Sinai Cancer and Tempus, a leader in artificial intelligence and precision medicine, are harnessing the power of big data and AI to design personalized cancer treatment options by creating virtual replicas of patients’ DNA, RNA, protein and other information to help identify the most effective approach to each individual’s disease. By creating these “molecular twins,” scientists…
Collaboration combines industry-leading decentralized clinical trial expertise with deep genomic insights to create home-based clinical trial model designed to expand patient access to clinical research LOS ANGELES & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Science 37 and Foundation Medicine today announced a collaboration to enable decentralized clinical research in oncology that will optimize…
CAMBRIDGE, MA, Sept. 7, 2021 – ConcertAI, LLC (ConcertAI), a market leader for real-world evidence and enterprise AI Software-as-a-Service solutions for precision oncology, hematology, and urology, announced the appointment of Lauren Gordon as its first chief people officer. Gordon will lead all aspects of ConcertAI’s human resources (HR) strategy, including talent acquisition, learning…
Company adds clinical, technology, and business expertise to catalyze next stage of growth SAN FRANCISCO, Sept. 30, 2021 /PRNewswire/ — Verana Health, a digital health data company that delivers insights from unfiltered healthcare data with integrity to connect the dots between patient care and clinical research, today announced several additions to its leadership…
Sponsored by Syntropy | Aug 23, 2021 8:00am Life science organizations and academic medical centers have an opportunity to advance scientific research by leveraging data, but there is one major roadblock: stakeholders have competing incentives. Technology adoption and integration of data is not blocking advancement. To the contrary, the lack of aligned incentives…
Initial projects demonstrate platform’s ability to efficiently and effectively aggregate disparate data, enable team science Houston ― The University of Texas MD Anderson Cancer Center today announced efforts to advance its capabilities to seamlessly connect basic science, translational and clinical research data for the benefit of patients through a technology collaboration…
01-Feb-2021 By Jenni Spinner The panel is intended to address ethical matters that arise around evolving data and digital conduct for all of its various business sectors. Source: https://www.outsourcing-pharma.com/Article/2021/02/01/Merck-Digital-Ethics-Advisory-Panel-tackles-tech-questions?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
by Conor Hale | Jan 14, 2021 12:46pm Using artificial intelligence and remote patient monitoring services, the two companies hope to provide highly personalized solutions to help maximize the chance of conception. (Philips)ShareFacebookTwitterLinkedInEmailPrint Philips and Germany’s Merck KGaA have launched a multi-year partnership to help bring digital technologies to fertility treatments—combining informatics, mobile…
08 JAN 2021 | DARMSTADT, GERMANY Panel designed to provide ethical counsel to inform all business processes, supporting the evolving data-driven, digital landscape Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the creation of its Digital Ethics Advisory Panel. Designed to provide guidance around evolving digital business models,…